Yamaguchi, Hirohito
The University of Texas MD Anderson Cancer Center
3 papers on CoChatORCID 0000-0003-0425-916X
Most cited papers
- Verified
PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression
Jiao, S., Xia, W., Yamaguchi, H., Wei, Y., Chen, M.-K., Hsu, J.-M., Hsu, J. L., Yu, W.-H., Du, Y., Lee, H.-H., et al. (2017) · Clinical Cancer Research
PARP inhibition in cancer therapyCancer Immunotherapy and Biomarkers
Cited by 981
- Verified
Deubiquitination and Stabilization of PD-L1 by CSN5
Lim, S.-O., Li, C.-W., Xia, W., Cha, J.-H., Chan, L.-C., Wu, Y., Chang, S.-S., Lin, W.-C., Hsu, J.-M., Hsu, Y.-H., et al. (2016) · Cancer Cell
Cancer Immunotherapy and BiomarkersUbiquitin and proteasome pathways
Cited by 793
- Verified
PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response.
Liao, H.-W., Hsu, J.-M., Xia, W., Wang, H.-L., Wang, Y.-N., Chang, W.-C., Arold, S. T., Chou, C.-K., Tsou, P.-H., Yamaguchi, H., et al. (2015) · Journal of Clinical Investigation
HER2/EGFR in Cancer ResearchCancer-related gene regulation
Cited by 155
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free